Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:01 PM ET 8-K
Investor Presentation Avista Corp AVA

Avista Investor Presentation

Avista Corp. has made available its November 2026 investor presentation detailing its strategic priorities, including a $3.6 billion capital expenditure plan for 2027-2031. The presentation highlights the company's long-term utility earnings growth target of 4-6% and its aspirational goals for 100% clean electricity by 2045.

5:01 PM ET 8-K
Capacity Expansion AST SpaceMobile, Inc. ASTS

AST SpaceMobile Capacity Expansion

AST SpaceMobile announced plans to build its own 20-ton rocket to deploy its BlueBird satellites in low-Earth orbit. The company will utilize Miranda engines from Firefly Aerospace for the launch vehicle, representing a major vertical integration of its satellite deployment infrastructure.

Counterparty
Firefly Aerospace, Inc.
5:01 PM ET 8-K
Shareholder Meeting Cvd Equipment Corp CVV

Cvd Equipment Shareholder Meeting

CVD Equipment Corporation held its 2026 Annual Meeting of Shareholders on November 5, 2026. Shareholders elected five directors to serve until the 2027 Annual Meeting, ratified CBIZ CPAs P.C. as the independent auditor for fiscal year 2026, and approved a non-binding advisory resolution on executive compensation.

5:01 PM ET 8-K
Business Update First Breach, Inc. FBDT

First Breach Business Update

First Breach announced a strategic supply agreement to purchase up to 20 million primers per month and a separate raw material sourcing agreement to support its production ramp. The company also added two ammunition inspection units to its Hagerstown facility as it scales toward a capacity of 20 million rounds per month and transitions to 24-hour operations.

5:00 PM ET 8-K
Loan & Debt TuHURA Biosciences, Inc. HURA

TuHURA Biosciences $50M Debt Financing with Parkview Holdings One LLC

TuHURA Biosciences borrowed an additional $1.5 million under its existing revolving credit facility with Parkview Holdings One LLC. The facility, which matures in April 2031, has a maximum loan availability of $50 million. The company intends to use the proceeds for general corporate purposes.

Value
$50M
Counterparty
Parkview Holdings One LLC
Term
through April 2031
5:00 PM ET 8-K
Reverse Stock Split Treasure Global Inc TGL

Treasure Global Reverse Stock Split

Stockholders approved an amendment to the Certificate of Incorporation authorizing the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-50. The move is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement (Listing Rule 5550(a)(2)).

5:00 PM ET Form 4
Insider Selling SI-BONE, Inc. SIBN

SI-BONE Chief Op & Financial Officer Anshul Maheshwari Sells $81.2K of Stock

Anshul Maheshwari, Chief Op & Financial Officer, sold 3,247 shares of SI-BONE, Inc. at $25.00 a share, worth $81.2K in total on Nov 4, 2026. Shares held after the trade: 211,250 (-1.5%).

Value
$81.2K
Shares
3,247
Price
$25.00
Role
Chief Op & Financial Officer
Holding change
-1.5%
Trade date
Nov 4, 2026
5:00 PM ET Form 4
Insider Selling Delta Air Lines, Inc. DAL

Delta Air Lines President Peter W. Carter Sells $4.01M of Stock

Peter W. Carter, President, sold 44,950 shares of Delta Air Lines, Inc. at $89.29 a share, worth $4.01M in total on Nov 4, 2026. Shares held after the trade: 379,754 (-10.6%).

Value
$4.01M
Shares
44,950
Price
$89.29
Role
President
Holding change
-10.6%
Trade date
Nov 4, 2026
5:00 PM ET Form 4
Insider Selling Cullinan Therapeutics, Inc. CGEM

Cullinan Therapeutics CSO Jennifer Michaelson Sells $49.4K of Stock

Jennifer Michaelson, CSO, sold 4,000 shares of Cullinan Therapeutics, Inc. at $12.36 a share, worth $49.4K in total on Nov 5, 2026. Shares held after the trade: 158,649 (-2.5%).

Value
$49.4K
Shares
4,000
Price
$12.36
Role
CSO
Holding change
-2.5%
Trade date
Nov 5, 2026
5:00 PM ET 10-Q
Financial Results abrdn Precious Metals Basket ETF Trust GLTR

abrdn Precious Metals Basket ETF Trust Q3 2026 Results: Net Income $84.2M, Down 70.1% YoY

For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $296 million, primarily driven by a $314.6 million change in unrealized loss on bullion. Despite the operational loss, net assets grew to $2.6 billion due to $382.9 million in share creations, while the net asset value per share decreased from $206.19 to $187.41 during the period.

Key figure
Net income $84.2M · -70.1% YoY
5:00 PM ET Form 4
Insider Selling Appfolio Inc APPF

Appfolio 10% Owner Maurice J. Duca Sells $2.59M of Stock

Maurice J. Duca, 10% Owner, sold 10,800 shares of Appfolio Inc at $240.00 to $240.15 a share (average $240.08) in 6 transactions, worth $2.59M in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 27,700 (-5.5%).

Value
$2.59M
Shares
10,800
Average price
$240.08
Role
10% Owner
Holding change
-5.5%
Trade date
Nov 4, 2026 to Nov 5, 2026
5:00 PM ET 10-Q
Financial Results Establishment Labs Holdings Inc. ESTA

Establishment Labs Holdings Q3 2026 Results: Net Loss of $10.7M, Loss Narrows

Establishment Labs Holdings Inc. reported 29,823,470 common shares outstanding as of November 5, 2026. The company's balance sheet shows a stable cash position of $75.8 million as of September 30, 2026, compared to $75.6 million at the end of 2025, while total current assets increased slightly to $255.7 million.

Key figure
Net loss $10.7M
4:59 PM ET Form 4
Insider Selling Block, Inc. XYZ

Block Insider Anthony Mathew Eisen Sells $3.06M of Stock

Anthony Mathew Eisen sold 35,000 shares of Block, Inc. at $87.50 a share, worth $3.06M in total on Nov 4, 2026. Shares held after the trade: 1,177,672 (-2.9%).

Value
$3.06M
Shares
35,000
Price
$87.50
Holding change
-2.9%
Trade date
Nov 4, 2026
4:58 PM ET 10-Q
Financial Results Medical Properties Trust Inc MPT

Medical Properties Trust Q3 2026 Results: Turns Profitable, Net Income $202M

For the quarter ended September 30, 2026, Medical Properties Trust reported net income of $202.1 million, a significant recovery from a net loss of $77.5 million in the prior year period, primarily driven by a $157.8 million gain on the sale of real estate. Total revenues increased to $250.1 million from $237.5 million, while the company maintained a quarterly dividend of $0.09 per share.

Key figure
Net income $202M
4:58 PM ET 10-Q
Financial Results MPT Operating Partnership, L.P. MPW

MPT Operating Partnership Q3 2026 Results: Turns Profitable, Net Income $202M

For the nine months ended September 30, 2026, Medical Properties Trust reported net income of $232.9 million, a significant recovery from a net loss of $293.5 million in the prior year period. The improvement was driven by higher billed rent and a substantial gain on the sale of real estate totaling $163.4 million.

Key figure
Net income $202M
4:58 PM ET 10-Q
Financial Results Invesco Mortgage Capital Inc. IVR

Invesco Mortgage Capital Q3 2026 Results: Net Loss of $95.6M

Invesco Mortgage Capital Inc. reported a net loss of $80.5 million for the nine months ended September 30, 2026, compared to a net income of $49.8 million in the prior year period. The loss was primarily driven by a $478.2 million net loss on investments, despite a significant increase in net interest income to $91.1 million. Total assets grew to $7.8 billion as of September 30, 2026, up from $6.5 billion at the end of 2025.

Key figure
Net loss $95.6M
4:58 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.17M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,950 shares of United Therapeutics Corp at $593.14 to $602.49 a share (average $597.75) in 8 transactions, worth $1.17M in total on Nov 5, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$1.17M
Shares
1,950
Average price
$597.75
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 5, 2026
4:57 PM ET Form 4
Insider Selling Crocs, Inc. CROX

Crocs Insider Douglas J. Treff Sells $1.71M of Stock

Douglas J. Treff sold 10,714 shares of Crocs, Inc. at $159.21 a share, worth $1.71M in total on Nov 4, 2026. Shares held after the trade: 61,371 (-14.9%).

Value
$1.71M
Shares
10,714
Price
$159.21
Holding change
-14.9%
Trade date
Nov 4, 2026
4:55 PM ET Form 4
Insider Buying Kodiak Sciences Inc. KOD

Kodiak Sciences Director Baker Bros. Advisors LP Buys $24.3M of Stock

Baker Bros. Advisors LP, Director, bought 247,090 shares of Kodiak Sciences Inc. at $98.51 a share, worth $24.3M in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 20,424,859 (+0.4%).

Value
$24.3M
Shares
247,090
Average price
$98.51
Role
Director
Holding change
+0.4%
Trade date
Nov 4, 2026 to Nov 5, 2026
4:55 PM ET 10-Q
Financial Results abrdn Platinum ETF Trust PPLT

abrdn Platinum ETF Trust Q3 2026 Results: Net Income $160M, Down 38.2% YoY

For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $424.7 million, primarily driven by a $750.9 million unrealized loss on platinum. During the period, the Trust also executed a ten-for-one forward share split on May 14, 2026, and saw its net asset value per share decrease from $18.41 to $15.50.

Key figure
Net income $160M · -38.2% YoY
4:55 PM ET 8-K
Financial Results Cps Technologies Corp CPSH

Cps Technologies Financial Results

CPS Technologies reported record quarterly revenue of $8.9 million and a net income of $0.6 million for Q3 2026. The company achieved gross margin expansion to 20.9% and signed a long-term lease for a new 80,000-square-foot facility in Attleboro, Massachusetts to double its production capacity.

Term
Q3 2026

“We are pleased to report solid progress this quarter on a number of fronts. Due to higher demand and increased production, our quarterly revenue rose to a new high and gross margins expanded to 20.9% – a level not seen since during our HybridTech Armor® contracts more than three years ago.”

Brian Mackey, President and CEO

“This proves the resilience of our product lines, interest in our broadening portfolio of offerings, and sound operating execution. We also recently announced the signing of a lease in nearby Attleboro that will allow CPS to further expand operations in support of increased top line growth and higher returns for our shareholders.”

Brian Mackey, President and CEO
4:55 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.33M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,540 shares of United Therapeutics Corp at $562.51 to $591.54 a share (average $573.89) in 24 transactions, worth $4.33M in total on Nov 5, 2026. Shares held after the trade: 326,403 (-0.0%).

Value
$4.33M
Shares
7,540
Average price
$573.89
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 5, 2026
4:53 PM ET 10-Q
Financial Results abrdn Palladium ETF Trust PALL

abrdn Palladium ETF Trust Q3 2026 Results: Net Loss of $6.15M

As of September 30, 2026, the Trust held $637.6 million in palladium, a decrease from $1.0 billion at the end of 2025, primarily driven by significant net redemptions and a $259.5 million unrealized loss. The Trust continues to operate as a grantor trust with a 0.60% annual Sponsor's Fee paid through in-kind palladium transfers.

Key figure
Net loss $6.15M
4:53 PM ET 10-Q
Financial Results Cathay General Bancorp CATY

Cathay General Bancorp Q3 2026 Results: Net Income $95.2M, Up 22.6% YoY

Cathay General Bancorp reported net income of $95.2 million for the third quarter of 2026, an increase from $77.7 million in the prior year period. Total assets grew to $25.6 billion, driven by a $1.1 billion net increase in loans and a $940.8 million increase in deposits during the first nine months of the year.

Key figure
Net income $95.2M · +22.6% YoY
4:53 PM ET Form 4
Insider Selling Regional Management Corp. RM

Regional Management Director Sandra K. Johnson Sells $104K of Stock

Sandra K. Johnson, Director, sold 2,700 shares of Regional Management Corp. at $38.27 to $39.45 a share (average $38.57) in 2 transactions, worth $104K in total on Nov 5, 2026. Shares held after the trade: 17,873 (-3.7%).

Value
$104K
Shares
2,700
Average price
$38.57
Role
Director
Holding change
-3.7%
Trade date
Nov 5, 2026
4:52 PM ET Form 4
Insider Selling Kiniksa Pharmaceuticals International, plc KNSA

Kiniksa Pharmaceuticals International Chairman & CEO Sanj K. Patel Sells $14.3M of Stock

Sanj K. Patel, Chairman & CEO, sold 151,300 shares of Kiniksa Pharmaceuticals International, plc at $92.35 to $96.05 a share (average $94.71) in 5 transactions, worth $14.3M in total on Nov 4, 2026. Shares held after the trade: 774,500 (-3.4%).

Value
$14.3M
Shares
151,300
Average price
$94.71
Role
Chairman & CEO
Holding change
-3.4%
Trade date
Nov 4, 2026
4:52 PM ET 10-Q
Financial Results Radian Group Inc RDN

Radian Group Q3 2026 Results: Net Income $164M, Up 15.7% YoY

Radian Group Inc. reported its 2026 third-quarter results, highlighting the February 2026 acquisition of Inigo and the subsequent wind-down of its Mortgage Conduit business. The company also announced the sale of its Real Estate Services business in August 2026 and entered a definitive agreement to sell Radian Title Insurance, classifying both as discontinued operations.

Key figure
Net income $164M · +15.7% YoY
4:52 PM ET Form 4
Insider Buying Dream Finders Homes, Inc. DFH

Dream Finders Homes Director Len Sturm Buys $10.5K of Stock

Len Sturm, Director, bought 1,000 shares of Dream Finders Homes, Inc. at $10.53 a share, worth $10.5K in total on Nov 4, 2026. Shares held after the trade: 31,728 (+3.3%).

Value
$10.5K
Shares
1,000
Price
$10.53
Role
Director
Holding change
+3.3%
Trade date
Nov 4, 2026
4:52 PM ET 10-Q
Financial Results J.P. Morgan Real Estate Income Trust, Inc.

J.P. Morgan Real Estate Income Trust Q3 2026 Results: Turns Profitable, Net Income $286K

J.P. Morgan Real Estate Income Trust, Inc. reported total revenues of $94.9 million for the nine months ended September 30, 2026, a significant increase from $44.1 million in the prior year period. Despite the revenue growth, the company recorded a net loss attributable to stockholders of $1.3 million for the nine-month period, though it achieved a quarterly net income of $0.4 million in Q3 2026.

Key figure
Net income $286K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.